Anemia in Critically Ill Infants: Causes, Diagnosis, and Treatment
In critically ill infants, anemia is primarily caused by blood loss (phlebotomy, hemorrhage), hemolysis (immune-mediated or inherited disorders), and decreased red blood cell production (anemia of inflammation), with treatment requiring a restrictive transfusion strategy targeting hemoglobin thresholds of 7-8 g/dL in stable infants and 10-11 g/dL in those with severe cardiopulmonary disease, while addressing underlying causes.
Causes of Anemia in Critically Ill Infants
Blood Loss
- Iatrogenic phlebotomy: The leading cause in extremely low birthweight (ELBW) infants in the NICU, accounting for much of the anemia burden 1
- Acute hemorrhage: External or internal bleeding from trauma, surgery, or vascular access complications
- Chronic blood loss: Ongoing losses from renal replacement therapy or repeated procedures
Hemolysis
- Immune-mediated: Haemolytic disease of the fetus and newborn (HDFN) from maternal IgG antibodies crossing the placenta, targeting Rh antigens (D, C, c, E, e), Kell, or Duffy antigens 2
- Inherited disorders: G6PD deficiency, alpha-thalassemia, hereditary spherocytosis 3
- Sepsis-associated: Secondary autoimmune hemolytic anemia triggered by severe infection 4
Decreased Production
- Anemia of inflammation: Blunted erythropoietin production, elevated hepcidin causing iron-restricted erythropoiesis, and inflammatory cytokines (TNF, IL-1, IL-6) suppressing bone marrow 5
- Iron deficiency: From inadequate intake, prematurity with depleted stores, or excessive cow's milk consumption (>24 oz/day) 6
- Nutritional deficiencies: Vitamin B12 or folate deficiency, particularly in infants with extensive small bowel disease 7
- Congenital disorders: Pure red cell aplasia (rare) 3
Diagnostic Workup
Initial Screening
Screen all high-risk infants at 9-12 months of age, then 6 months later 6. High-risk groups include:
- Preterm or low birthweight infants
- Infants on non-iron-fortified formula >2 months
- Early introduction of cow's milk (<12 months)
- Breastfed infants with inadequate iron supplementation after 6 months
- Infants with chronic illness, medications interfering with iron absorption, or blood loss 6
Minimum Laboratory Workup
When hemoglobin is below normal, obtain 7:
- Complete blood count with red cell indices (MCV, RDW)
- Reticulocyte count: Low/normal suggests production defect; elevated suggests hemolysis or blood loss
- Serum ferritin: ≤15 μg/L confirms iron deficiency 6
- Transferrin saturation
- C-reactive protein: Elevated suggests inflammation masking iron deficiency
Extended Workup (if cause unclear)
- MCV interpretation: Microcytosis (low MCV) indicates iron deficiency or thalassemia; macrocytosis suggests B12/folate deficiency 7
- RDW >14% with low MCV confirms iron deficiency over thalassemia 6
- Hemolysis markers: Haptoglobin, lactate dehydrogenase, indirect bilirubin, direct/indirect Coombs test 7, 4
- Vitamin B12 and folate levels
- Hematology consultation if diagnosis remains unclear 7
Critical Pitfall
In the presence of inflammation (elevated CRP), serum ferritin >15 μg/L does not exclude iron deficiency—functional iron deficiency can coexist with elevated ferritin due to acute phase response 7. Consider transferrin saturation and percentage of hypochromic red cells in this context.
Treatment
Transfusion Strategy
Use restrictive transfusion thresholds in stable preterm neonates 8:
- Hemoglobin 7-8 g/dL for clinically stable infants
- Hemoglobin 10-11 g/dL for infants with severe cardiopulmonary disease, active bleeding, or hemodynamic instability 9, 8
This restrictive approach is based on moderate certainty evidence showing no increased mortality or major morbidity compared to liberal strategies, while reducing donor exposures 8. Transfuse packed red blood cells at 10-15 mL/kg over 2-4 hours; in acute severe hemorrhage with shock, may transfuse at 30 mL/kg/hour with close monitoring 4.
Iron Deficiency Anemia Treatment
Prescribe 3 mg/kg/day of elemental iron drops between meals 6. Recheck hemoglobin in 4 weeks:
- Response confirmed: Hemoglobin increase ≥1 g/dL or hematocrit ≥3% confirms diagnosis
- Continue iron for 2 additional months, then recheck
- Reassess 6 months after completing treatment 6
If no response after 4 weeks despite compliance, obtain MCV, RDW, and serum ferritin to identify alternative causes (thalassemia, chronic disease, lead poisoning) 6.
Dietary Counseling (Prevention)
- Encourage exclusive breastfeeding for 4-6 months 6
- Iron-fortified formula if not breastfeeding or partially breastfed 6
- Preterm/low birthweight infants: 2-4 mg/kg/day iron drops starting at 1 month until 12 months 6
- Introduce iron-fortified cereal at 4-6 months (≥2 servings/day meets requirements) 6
- Vitamin C-rich foods daily with meals to enhance iron absorption 6
- Limit cow's milk to <24 oz/day after 12 months 6
Hemolytic Disease Management
For HDFN with severe anemia 2:
- Intrauterine transfusions if fetal anemia develops early
- Intravenous immunoglobulin (IVIG) weekly to mother at high risk, starting late first trimester to delay/prevent severe anemia
- Postnatal phototherapy for hyperbilirubinemia
- Exchange transfusion if severe anemia with maternal antibodies persists postnatally
Patient Blood Management
Minimize iatrogenic blood loss 5:
- Reduce phlebotomy volumes using pediatric collection tubes
- Consolidate laboratory draws
- Use point-of-care testing when appropriate
- Limit unnecessary repeat testing
Special Considerations
Sepsis-associated hemolytic anemia requires aggressive treatment of underlying infection with broad-spectrum antibiotics (e.g., cefepime and vancomycin), supportive transfusions, and consideration of immunotherapy in refractory cases 4. Monitor for disseminated intravascular coagulation with fibrin split products and fibrinogen levels.
Anemia of inflammation in critically ill infants responds poorly to erythropoietin in the era of restrictive transfusion practice; focus on treating underlying inflammation and optimizing iron availability 5, 10.